• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Characteristics of Adult Patients with Idiopathic Retroperitoneal Fibrosis and Assessment of Risk of Relapse at Diagnosis.特发性腹膜后纤维化成年患者的特征及诊断时复发风险评估
J Clin Med. 2021 Mar 30;10(7):1380. doi: 10.3390/jcm10071380.
2
Risk factors for relapse and long-term outcome of idiopathic retroperitoneal fibrosis.特发性腹膜后纤维化的复发风险因素和长期预后。
Clin Exp Nephrol. 2019 Sep;23(9):1147-1153. doi: 10.1007/s10157-019-01759-w. Epub 2019 Jun 22.
3
[Idiopathic retroperitoneal fibrosis: a multicentric retrospective study of 30 French cases and follow-up of the renal function].[特发性腹膜后纤维化:30例法国病例的多中心回顾性研究及肾功能随访]
Rev Med Interne. 2014 Sep;35(9):570-6. doi: 10.1016/j.revmed.2013.11.006. Epub 2013 Dec 6.
4
[Idiopathic retroperitoneal fibrosis: clinico-pathological characteristics].[特发性腹膜后纤维化:临床病理特征]
Nefrologia. 2009;29(4):298-303. doi: 10.3265/Nefrologia.2009.29.4.5344.en.full.
5
Persistent FDG/PET CT uptake in idiopathic retroperitoneal fibrosis helps identifying patients at a higher risk for relapse.特发性腹膜后纤维化患者 FDG/PET CT 摄取持续存在有助于识别复发风险较高的患者。
Eur J Intern Med. 2019 Apr;62:67-71. doi: 10.1016/j.ejim.2019.01.019. Epub 2019 Jan 31.
6
Idiopathic Retroperitoneal Fibrosis: Long-term Risk and Predictors of Relapse.特发性腹膜后纤维化:长期复发风险和预测因素。
Am J Kidney Dis. 2019 Dec;74(6):742-750. doi: 10.1053/j.ajkd.2019.04.020. Epub 2019 Jun 14.
7
Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomised controlled trial.泼尼松与他莫昔芬治疗特发性腹膜后纤维化患者的疗效比较:一项开放标签随机对照试验。
Lancet. 2011 Jul 23;378(9788):338-46. doi: 10.1016/S0140-6736(11)60934-3. Epub 2011 Jul 4.
8
Long-term outcomes and predictors of a large cohort of idiopathic retroperitoneal fibrosis patients: a retrospective study.特发性腹膜后纤维化患者的大样本队列的长期预后及其预测因素:一项回顾性研究。
Scand J Rheumatol. 2019 May;48(3):239-245. doi: 10.1080/03009742.2018.1497700. Epub 2018 Sep 30.
9
Idiopathic retroperitoneal fibrosis: clinical features, treatment modalities, relapse rate in Greek patients and a review of the literature.特发性腹膜后纤维化:希腊患者的临床特征、治疗方式、复发率及文献复习。
Clin Exp Rheumatol. 2022 Sep;40(9):1642-1649. doi: 10.55563/clinexprheumatol/umzfau. Epub 2021 Nov 11.
10
Idiopathic retroperitoneal fibrosis: clinicopathologic features and outcome analysis.特发性腹膜后纤维化:临床病理特征及预后分析
Clin Rheumatol. 2016 Feb;35(2):401-7. doi: 10.1007/s10067-015-3022-y. Epub 2015 Jul 25.

引用本文的文献

1
Combined therapy of prednisone and mTOR inhibitor sirolimus for treating retroperitoneal fibrosis.泼尼松和 mTOR 抑制剂西罗莫司联合治疗腹膜后纤维化。
Ann Rheum Dis. 2023 May;82(5):688-697. doi: 10.1136/ard-2022-223736. Epub 2023 Jan 31.
2
Idiopathic retroperitoneal fibrosis with endometrial cancer: a case report and literature review.特发性腹膜后纤维化合并子宫内膜癌:病例报告及文献复习。
BMC Womens Health. 2022 Oct 1;22(1):399. doi: 10.1186/s12905-022-01968-8.

本文引用的文献

1
The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease.2019 年美国风湿病学会/欧洲抗风湿病联盟 IgG4 相关疾病分类标准。
Ann Rheum Dis. 2020 Jan;79(1):77-87. doi: 10.1136/annrheumdis-2019-216561. Epub 2019 Dec 3.
2
Fibrocytes in Chronic Periaortitis: A Novel Mechanism Linking Inflammation and Fibrosis.慢性主动脉周围炎中的纤维细胞:炎症与纤维化相关的新机制。
Arthritis Rheumatol. 2019 Nov;71(11):1913-1922. doi: 10.1002/art.41024. Epub 2019 Sep 30.
3
Risk factors for relapse and long-term outcome of idiopathic retroperitoneal fibrosis.特发性腹膜后纤维化的复发风险因素和长期预后。
Clin Exp Nephrol. 2019 Sep;23(9):1147-1153. doi: 10.1007/s10157-019-01759-w. Epub 2019 Jun 22.
4
Cigarette Smoking-Mediated Macrophage Reprogramming: Mechanistic Insights and Therapeutic Implications.吸烟介导的巨噬细胞重编程:机制洞察与治疗意义
J Nat Sci. 2018 Nov;4(11).
5
Persistent FDG/PET CT uptake in idiopathic retroperitoneal fibrosis helps identifying patients at a higher risk for relapse.特发性腹膜后纤维化患者 FDG/PET CT 摄取持续存在有助于识别复发风险较高的患者。
Eur J Intern Med. 2019 Apr;62:67-71. doi: 10.1016/j.ejim.2019.01.019. Epub 2019 Jan 31.
6
Rituximab for idiopathic and IgG4-related retroperitoneal fibrosis.利妥昔单抗治疗特发性和IgG4相关性腹膜后纤维化。
Medicine (Baltimore). 2018 Oct;97(42):e12631. doi: 10.1097/MD.0000000000012631.
7
[F]-Fluorodeoxyglucose Positron Emission Tomography and Response to Therapy in Idiopathic Retroperitoneal Fibrosis.[F]-氟脱氧葡萄糖正电子发射断层扫描与特发性腹膜后纤维化的治疗反应
Eur Urol. 2018 Jan;73(1):145-146. doi: 10.1016/j.eururo.2017.09.024. Epub 2017 Oct 13.
8
Induction of murine macrophage M2 polarization by cigarette smoke extract via the JAK2/STAT3 pathway.香烟烟雾提取物通过JAK2/STAT3途径诱导小鼠巨噬细胞M2极化
PLoS One. 2014 Sep 8;9(9):e107063. doi: 10.1371/journal.pone.0107063. eCollection 2014.
9
Role of diffusion-weighted MR imaging in the differentiation of benign retroperitoneal fibrosis from malignant neoplasm: preliminary study.弥散加权磁共振成像在良性腹膜后纤维化与恶性肿瘤鉴别诊断中的作用:初步研究。
Radiology. 2014 Aug;272(2):438-45. doi: 10.1148/radiol.14131565. Epub 2014 Apr 1.
10
[Idiopathic retroperitoneal fibrosis: a multicentric retrospective study of 30 French cases and follow-up of the renal function].[特发性腹膜后纤维化:30例法国病例的多中心回顾性研究及肾功能随访]
Rev Med Interne. 2014 Sep;35(9):570-6. doi: 10.1016/j.revmed.2013.11.006. Epub 2013 Dec 6.

特发性腹膜后纤维化成年患者的特征及诊断时复发风险评估

Characteristics of Adult Patients with Idiopathic Retroperitoneal Fibrosis and Assessment of Risk of Relapse at Diagnosis.

作者信息

Razanamahery Jerome, Bouldoires Bastien, Humbert Sebastien, Bielefeld Philip, Fournier Veronique, Bonnotte Bernard, Blaison Gilles, Magy-Bertrand Nadine

机构信息

Department of Internal Medicine and Clinical Immunology, Dijon University Hospital, 21000 Dijon, France.

Department of Internal Medicine, Hopital Pasteur, 68000 Colmar, France.

出版信息

J Clin Med. 2021 Mar 30;10(7):1380. doi: 10.3390/jcm10071380.

DOI:10.3390/jcm10071380
PMID:33808093
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8038021/
Abstract

OBJECTIVES

To compare adult patients' characteristics suffering from idiopathic retroperitoneal fibrosis between "relapse-free" and relapsing patients at the diagnosis and identify factors associated with relapse at initial presentation.

METHODS

We conducted a retrospective multicentric study in four hospitals in Eastern France, from 1993 to 2020, of adult patients suffering from idiopathic retroperitoneal fibrosis. We analyzed clinical, biological, and radiological features at diagnosis and during a forty-month follow-up.

RESULTS

Of 47 patients suffering from retroperitoneal fibrosis, 21 patients had idiopathic retroperitoneal fibrosis. Among them, 13 experienced one or more relapses during follow-up. At diagnosis, clinical characteristics, relevant comorbidities, biological and radiological features were similar between groups. Smoking cessation seems associated with decreased relapse risk (: 0.0624). A total of 8 patients developed chronic renal failure during follow-up. Ureteral infiltration at diagnosis was associated with evolution to chronic renal failure (: 0.0091).

CONCLUSION

No clinical, biological, or radiological features could predict relapse at retroperitoneal fibrosis diagnosis, but smoking cessation may prevent relapse.

摘要

目的

比较“无复发”和复发的特发性腹膜后纤维化成年患者在诊断时的特征,并确定初始表现时与复发相关的因素。

方法

我们于1993年至2020年在法国东部的四家医院进行了一项回顾性多中心研究,研究对象为患有特发性腹膜后纤维化的成年患者。我们分析了诊断时以及40个月随访期间的临床、生物学和放射学特征。

结果

在47例腹膜后纤维化患者中,21例患有特发性腹膜后纤维化。其中,13例在随访期间经历了一次或多次复发。诊断时,两组间的临床特征、相关合并症、生物学和放射学特征相似。戒烟似乎与复发风险降低相关(:0.0624)。共有8例患者在随访期间出现慢性肾衰竭。诊断时输尿管受累与发展为慢性肾衰竭相关(:0.0091)。

结论

在腹膜后纤维化诊断时,没有临床、生物学或放射学特征能够预测复发,但戒烟可能预防复发。